Delivery Order SPE2DB22D2006-SPE2DB24FW1PP

Award Date 7/2/24
Potential Completion Date 7/3/24
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of 4,565,069,710 units of epinephrine 0.3 mg auto-injectors over a two-year period ending on July 5, 2024. The contract was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA). The contract has a firm fixed-price ceiling of $1,150.20 and was awarded without the use of any set-aside designations. Amerisourcebergen also holds a $999,999,999.00 Indefinite...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,840,504 units of the Epinephrine 0.3 mg auto-injector product. The $2,691.54 firm-fixed-price delivery order was awarded on June 7, 2024 by the Defense Logistics Agency (DLA) and has a completion date of June 10, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of 4,564,298,878 units of epinephrine 0.3 mg auto-injectors. The $2,851.10 firm fixed price delivery order contract has an ultimate completion date of April 17, 2024 and was awarded on April 16, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. This order is placed under Amerisourcebergen's existing Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,089,562 units of the epinephrine 0.15 mg auto-injector medical product. The $4,346.28 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) on July 8, 2024, with a completion date of July 9, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
This federal contract award, issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, provides for the delivery of 4,565,004,091 units of the Epinephrine 0.3 mg Auto-Injector, a critical medical supply, over the period ending on June 27, 2024. The $1,433.60 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA, under which the company supplies a wide...
This is a federal contract award to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract, valued at $1,202.30, is a delivery order for 4,565,004,145 epinephrine 0.3 mg auto-injector 2-packs. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of June 27, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is for the delivery of epinephrine auto-injectors (0.3 mg) over a 2-year period ending on April 30, 2024. The $1,284.00 firm-fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency that provides logistics, acquisition, and technical services to the U.S. Armed Forces. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the federal government,...
The U.S. Defense Logistics Agency (DLA) awarded a $1,786.95 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of 4,565,536,694 units of epinephrine 0.3 mg auto-injectors. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical...
This federal contract award is for the delivery of 4,566,149,251 units of Epinephrine 0.3 mg auto-injectors on a firm-fixed price basis. The $1,224.96 contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 18, 2024. The contract has an ultimate completion date of October 21, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,588.72 firm fixed price delivery order is for 4,565,586,337 units of epinephrine 0.15 mg auto-injectors. The award has an ultimate completion date of August 27, 2024 and is not a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW1PP
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,565,058,224 units of epinephrine 0.3 mg auto-injectors over the contract period ending on July 3, 2024. The award, valued at $1,495.30, was made by the Defense Logistics Agency (DLA) as a firm-fixed-price delivery order.

Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

This specific award was not set aside and was made on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market.

Generated 10/1/24, 10:18 AM